WellTheory raised $5M in new funding led by Samsung Next, Opal Ventures, and Up2 Fund to expand into employer and health plan markets and enhance its AI-powered care infrastructure.

May 22, 2025•7 months ago

Amount Raised

$5 Million

San FranciscoArtificial IntelligenceBiotechnologyHealth Care

Investors

Box GroupOvo FundAccelUp2 FundOpal VenturesSamsung Next

Description

WellTheory, based in San Francisco, CA, raised $5M to accelerate its expansion in the employer and health plan markets and improve its AI-powered care infrastructure. The funding includes participation from both new and existing investors. Led by CEO Ellen Rudolph, WellTheory offers a comprehensive virtual care platform for autoimmune diseases. Their latest AI tools support care teams by reducing prep time and enhancing care experience.

Company Information

Company

WellTheory

Location

San Francisco, California, United States

About

WellTheory is a virtual care platform reversing the autoimmune epidemic by filling the gaps left behind in traditional healthcare. WellTheory offers a research-backed proprietary program that addresses the root cause of autoimmunity and treats the whole person with the aim to reduce symptoms, improve quality of life, and lower costs. WellTheory’s platform centers around evidence-based, high-touch care led by an interdisciplinary team of autoimmune experts, including licensed registered dietitians and board-certified health coaches. It’s an anti-symptom-masking model that goes beyond the pill, built by autoimmune patients and validated by decades of clinical research.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns